Mankind Pharma Ltd. NSE: MANKIND | BSE: 543904

Expensive Rocket

2599.00 -9.50 (-0.36%)

331.2K

NSE+BSE Volume

NSE 11 Sep, 2025 3:55 PM (IST)

CDSCO Approval

Mankind Pharma gets CDSCO nod for Phase 1 trials of a molecule targeting autoimmune diseases See details

Mankind Pharma Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Mankind Pharma Ltd. from all sources in a single place.